PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Medicine and Health, Newcastle University, Newcastle upon Tyne, UK. Electronic address: Rachael.raw3@nhs.net.\', \'The School of Psychology, University of Sunderland, UK.\', \'The Department of Rheumatology, James Cook University Hospital, Middlesbrough, UK.\', \'The Department of Nephrology, James Cook University Hospital, Middlesbrough, UK.\', \'Centre for Clinical Infection, James Cook University Hospital, Middlesbrough, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(21)01577-210.1016/j.vaccine.2021.11.090
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34895935
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all